Portfolio Bar

BioProcess International Conference & Exposition

BPI Is Engineered to Be Exactly What You Need It to Be…

Register Onsite

Conference: October 26-29, 2015 * Exposition:  October 27-29, 2015 * John B Hynes Veterans Memorial Convention Center, Boston, MA


THE Industry Meeting Place to Exchange Real-World Solutions to Improve Speed, Cost and Quality

Conference: October 26-29, 2015 · Exhibition: October 17-19, 2015 · John B Hynes Veterans Memorial Convention Center · Boston, MA

Speaking Faculty

Speaking Faculty

  • Greg Adams, Ph.D., Director, Analytical Development, Fujifilm Diosynth Biotechnologies
  • Alina Alexeenko, Ph.D., Associate Professor, Purdue University
  • Jay Ankers, Director of Technology, M+W Group
  • Valentyn Antochshuk, Ph.D., Principal Scientist, Group Leader, Formulation Design and Process Compatibility, Merck
  • Amanda Ashcraft, Manager, Process Engineering/Development, Manufacturing Sciences and Technology, Genzyme, a Sanofi Company
  • Sujit Basu, Ph.D., Head, Drug and Combination Products, Research and Development, Shire
  • Rajesh G. Beri, Ph.D., Head, Mammalian Research and Technology, Lonza Biologics
  • Moumita Bhattacharya, Ph.D., Senior Scientist, Sterile Product and Analytical Development, Merck
  • Berthold Boedeker, Ph.D., Chief Scientist, Global Biologics-Biotech Development, Bayer Pharma AG
  • Marcus Boyer, Ph.D., Associate Director of Process Life-cycle Managemen, Bristol-Myers Squibb
  • Richard D. Braatz, Ph.D., Edward R. Gilliland Professor of Chemical Engineer, MIT
  • Lisa Bradbury, Ph.D., Director, Pall Corporation
  • Weiqiang Cheng, Ph.D., Process/Analytical Scientist, Genzyme, a Sanofi Company
  • Jonathan W Cooper, Ph.D., Staff Scientist, Analytical Development, Vaccine Production Program, NIAID/NIH
  • Carly Cox, Senior Process Engineer, Global Engineering, Pfizer
  • Suketu Desai, Ph.D., Vice President, Biologics Development, DS and DP, R&D, Allergan, Inc.
  • Susan J. Dexter, Senior Principal Consultant, Latham BioPharm Group
  • John Duguid, Principal Scientist, Vericel Corporation
  • Spencer Fisk, Global Head of Biologics Process R&D, Novartis Pharma AG
  • Bert Frohlich, Ph.D., Director, Process Controls and Quality by Design, Manufacturing Sciences & Technology, Shire
  • Arnab Ganguly, Ph.D., Technology Manager, IMA Life
  • Jason Goodrick, M.S., Senior Engineer, Group Leader, Late Stage Cell Culture, Genentech, A Member of the Roche Group
  • Ganapathy Gopalrathnam, Senior Research Scientist, Bioproduct Pharma Design/Formulations, Eli Lilly & Company
  • Nancy Green, Ph.D., Chief, Hormones and Enzymes Division, Biologics and Genetic Therapies Directorate, Health Canada
  • Ghada Haddad, Director, Engineering, Sterile & Validation CoE, Merck & Co.
  • Kimball M Hall, Vice President Manufacturing, Amgen Singapore Manufacturing PTE. Ltd.
  • Lisa Hardwick, Research Scientist, Baxter Healthcare Medical Products
  • Aaron Hubbard, Engineer 1, Pharmaceutical Processing & Technology Development, Genentech
  • Susan Dana Jones, Ph.D., Vice President and Principal Consultant, BioProcess Technology Consultants
  • Gabe Josset, Senior Associate Scientist, Biogen
  • Klaus Kaiser, Ph.D., Head of Downstream Processing and Analytics, Global Biological Development, Bayer Pharma AG
  • Martin Kane, Managing Data Scientist and Reliability Engineer, Exponent, Scientific and Engineering Con
  • Kevin Kerls, Senior Manager, Genentech, Inc. - A Member of the Roche
  • Kazumi Kobayashi, Ph.D., Senior Pirncipal Scientist, Technical Development, Biogen
  • David Kolwyck, M.S., MBA, Director, Manufacturing Sciences, Raw Material Global Process Owner, Biogen Idec
  • Sourav Kundu, Ph.D., Director, Biopharmaceutical Development, Teva Biopharmaceutical USA
  • Eric S. Langer, MSB, Managing Partner, BioPlan Associates, Inc.
  • Wallace Lauzon, Ph.D., Senior Evaluator, Cytokines Division, CERB, BGTD, Health Canada
  • Kelvin H. Lee, Ph.D., Gore Professor of Chemical & Biomolecular Engineer, Director, Delaware Biotechnology Institute, University of Delaware
  • Sheila G. Magil, Ph.D., Senior Consultant, BioProcess Technology Consultants
  • Kevin Maloney, Ph.D., Principal Scientist, Technical Development, Biogen
  • Rustom S. Mody, Ph.D., Head of R&D (Biotech Division), Lupin Limited
  • Mark D. Moody, Ph.D., Chief Scientific Advisor, Former VP Analytical Sciences, Merrimack Pharmacue, ReForm Biologics
  • Melissa Morandi, Vice President, Global Quality, Aegerion Pharmaceuticals
  • Benoit Mothes, PharmD, Scientific and Innovation DSP Head, Bioprocess Science and Technologies Department, Sanofi
  • Shamini Nathen, Senior Quality Engineer, Bristol-Myers Squibb
  • Kevin D. Ott, Executive Director, Bio-Process Systems Alliance
  • Veera Padmanabhan, Ph.D., Director, R&D, MedImmune
  • Anna Pisania, Ph.D., Staff Engineer, Acceleron
  • David J. Pollard, Ph.D., Executive Director, BioProcess Development, Merck & Co., Inc.
  • Daniel Py, President, MedInstill Development LLC
  • Kavita Ramalingam Iyer, Ph.D., Senior Specialist, Global Regulatory Affairs, Vaccine-CMC, Merck Sharp & Dohme Corp.
  • Govind Rao, Ph.D., Professor and Director, Center for Advanced Sensor Technology, University Of Maryland, Baltimore County
  • Kamal A. Rashid, Ph.D., Director and Research Professor, Biomanufacturing Education & Training Center, Worcester Polytechnic Institute (WPI)
  • Richard Reineke, Director, Upstream Manufacturing, Amgen, Inc.
  • Robert Repetto, M.S., MBA, Senior Director, External Affairs, Pfizer
  • Frank J. Riske, Ph.D., Consultant, Purification, BioProcess Technology Consultants
  • Nadine M. Ritter, Ph.D., President and Analytical Advisor, Global Biotech Experts, LLC
  • Debashis Sahoo, Director, Engineering, MedInstill Development LLC
  • Anthony Samawova, Senior Manager of Aseptic Filling Operations, Elusys Therapeutics
  • Joachim Schweizer, Senior Project Manager, Engineering & Technology, Boehringer Ingelheim Fremont
  • Anna Schwendeman, Ph.D., Assistant Professor, Medicinal Chemistry, University of Michigan
  • Deborah Shnek, Ph.D., Process Development Director, Drug Product Development LLC
  • Donald C. Singer, Quality Manager, Microbiology, R&D, GlaxoSmithKline
  • Narinder Singh, Director, Drug Product Technologies, Process Development, Amgen
  • Jeffrey Skene, Chief, Monoclonal Antibodies Division, Health Canada
  • Christopher J. Smalley, Ph.D., Director, Engineering, Global Technical Operations, Merck & Co.
  • Robert J. Steininger II, MSc., ASTM SubCommittee Chairman, Biotechnology, Consultant, BioPE, LLC
  • Suzanne Stuhler, Senior Process Engineer, Operations Technology & Innovation, Biogen Idec
  • Marco Thomann, Ph.D., Group Leader, Development Analytics, Roche Diagnostics GmbH
  • Matthew Traylor, Analytical Scientist, Process Development, Shire
  • Seshu Tummala, Ph.D., Principal Scientist, Research and Technology, Lonza Biologics Inc.
  • Varghese, Ph.D., Senior Director/Head, Analytical Development, Shire
  • Dushyant Varshney, Ph.D., Director, Manufacturing Assessment, MS&T, Hospira, Inc.
  • James Vogel, Founder and Director, The BioProcess Institute
  • Michael Washabaugh, Ph.D., Senior Director, Biopharmaceutical Development, MedImmune - a Member of the Astra Zeneca
  • Dominik Wegmann, Ph.D., Head of Manufacturing Science & Technology, Biological production, Lonza AG
  • Tony White, Director, BioPhorum Operations Group
  • Brian Wilbur, Scientist, Pfizer
  • Karl Dane Wittrup, Ph.D., C.P. Dubbs Professor of Chemical Eng. and Biol. En, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
  • Qian Wu, Ph.D., Director of Quality Control, XBiotech USA, Inc.
  • Mark Yang, Ph.D., Director of Fill Finish Development, Late Stage Process Development, Genzyme Corp.
  • Bernice Yeung, Ph.D., Director, Analytical Development, Rare Disease Unit, Shire Pharmaceuticals
  • Seongkyu Yoon, Ph.D., Assistant Professor and Director, Massachusetts Biomanufacturing Center, University of Massachusetts Lowell
  • Marcella Yu, Ph.D., Staff Scientist II, Commercial Cell Culture & Development, Genzyme, a Sanofi Company
  • Dénes Zalai, Ph.D. Candidate, Institute of Chemical Engineering, Vienna University of Technology
  • Gregory Zarbis-Papastoitsis, Ph.D., VP of Process and Manufacturing Sciences, Eleven Biotherapeutics
  • Ji Zheng, Ph.D., Senior Scientist II, Biologics Process Development, Bristol-Myers Squibb